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ABSTRACT 
Leptin, the product of the human homologue of the ob gene, which 
is defective in the obese (ob/ob) mouse, may be a humoral regulator 
of human adiposity. Plasma leptin concentrations were measured by 
RIA in 19 normal weight [body mass index (BMI) = 24.5 + 0.6 kg/m’] 
and 19 overweight to obese (BMI = 34.7 t 1.2 kg/m’) nondiabetic 
postmenopausal women on sequential controlled weight-maintaining 
diets containing 31%, 23%, and 14% of energy as fat, each for 4-6 
weeks. Thereafter, the subjects ate a very low fat diet (~15%) ad 
libitum; plasma leptin and insulin concentrations, BMI, percent body 
fat (%BF), and resting energy expenditure were determined after 6 
and 8 months. Absolute and adiposity-corrected plasma leptin levels 
were higher in overweight/obese women (37.7 -C 3.5 ng/mL; 1.01 2 
0.07 ng’mL “%BF-‘) than in normal weight women (16.9 2 2.2 
ng/mL; 0.57 + 0.06 ng’ mL-l’%BF-‘, both P < 0.005 us. obese), but 
were not different between the 31%, 23%, and 14% fat diets when body 
weight was stable. Plasma leptin was highly correlated with BMI (r = 
0.81, P < 0.00011, %BF (r = 0.80, P < O.OOOl), and fasting plasma 
insulin (r = 0.61, P < 0.0001). After 8 months on the ad libitum low 
fat diet, the women had lost an average of 6.9 2 1.0% of body mass 
(-2.0 + 0.3 kg/m’, P < 0.0001). In 15 subjects who lost more than 7% 
of body mass (- 12.3 t l.O%), plasma leptin concentrations decreased 
(-9.6 2 1.9 ng/mL, P < 0.0005), and the decrease of plasma leptin per 
change of adiposity (Aleptin/A%BF) was greater in overweight/obese 
women (3.6 t 0.5) than in normal weight women (0.9 + 0.4, P < 0.01 
us. obese). In 18 other subjects who lost less than 7% of body mass 
(-2.7 + 0.6%), plasma leptin was unchanged (+1.4 t 1.4 ng/mL). 
Overall, the change of plasma leptin was significantly correlated with 
change of BMI (r = 0.43, P < 0.02), the change of %BF (r = 0.49, P < 
0.0051, the change of resting energy expenditure (r = 0.40, P < 0.021, 
and with the change of plasma insulin independently of changes of 
body adiposity (r = 0.45, P < 0.01). We conclude that plasma leptin 
concentrations are: 1) not affected by dietary fat content per se; 2) 
highly correlated with BMI, %BF, and plasma insulin in both over- 
weight/obese and normal weight women; 3) decreased in parallel with 
plasma insulin after sustained weight loss; and 4) decreased more in 
overweight/obese than in normal weight women. (J Clin Endocrinol 
Metab 81: 4406-4413, 1996) 
T HE GENE responsible for hyperphagia and obesity in genetically obese (ob / ob) mice was recently cloned (1). 
The ob gene is expressed in adipose tissue (2) and its protein 
product, leptin, has been hypothesized to be a hormonal 
signal of body fat stores to the central nervous system, where 
it may act to limit food intake and increase energy expen- 
diture, and thereby regulate adiposity (3). Administration of 
recombinant leptin reduces food intake and produces weight 
loss (4-9), increases energy expenditure (4, B), and lowers 
plasma insulin and glucose (4,9) in ob/ ob mice. Leptin also 
decreases food intake and body weight in nonobese mice (4, 
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5,lO). Thus, a failure to produce adequate amounts of leptin 
or resistance to its central actions would result in the devel- 
opment of obesity. In the central nervous system, leptin may 
interact with central signals involved in food intake regula- 
tion such as neuropeptide-Y (9, ll), glucagon-like peptide-l 
(12), or another peripheral signal, insulin (13). Regulation of 
ob gene expression is now being investigated; studies in 
animals have shown increased expression after glucocorti- 
coid (14,15) or insulin administration (16,17) and decreased 
expression in insulin-deficient diabetic animals (18,19). Con- 
versely, genetic leptin deficiency or absolute leptin resistance 
appears to have direct or indirect effects on insulin action 
and/or secretion because ob / ob and db / db mice and fa / fa 
rats exhibit insulin resistance and hyperinsulinemia (20). The 
human homolog of the ob gene is overexpressed in adipose 
tissue of obese humans (21-23), and plasma leptin levels 
correlate with adiposity (22, 23). Thus, leptin may be in- 
volved, along with insulin (13), in the regulation of human 
adiposity. 
In rodents, obesity associated with high fat diets increases 
ob gene expression (24) and plasma leptin concentrations (25, 
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26), whereas ob gene expression (16-19, 24) and plasma 
leptin (26) are decreased in fasted us. fed animals. Although 
no short-term effects of meal ingestion on plasma leptin 
levels in humans have been noted (22, 23), diet composition 
could be a significant factor in the regulation of plasma 
leptin, especially when low fat diets are used to achieve 
weight loss. Plasma leptin levels and adipose ob gene ex- 
pression decrease with short-term weight loss on low fat 
diets in obese individuals (22, 23), although normal weight 
subjects were not examined, and in one study the decreases 
of plasma leptin after weight loss appeared to be transient 
(23). In the present study, with the use of a new sensitive and 
specific RIA for human leptin, we investigated the relation- 
ships between plasma leptin concentrations and body mass 
index (BMI), percent body fat, and plasma insulin in both 
normal weight and overweight to obese women when body 
weight was held constant on weight-maintaining diets con- 
taining 31%, 23%, and 14% of energy as fat, and again after 
6 and 8 months on an ad libitum very low fat diet (~15% fat) 
during which a subset of the subjects achieved and main- 
tained substantial reductions of body weight. 
Subjects 
Subjects and Methods 
Nineteen normal weight (BMI <27.8 kg/m*) and 19 overweight to 
obese (BMI >27.8 kg/m ) women participated in the study. All partic- 
ipants were screened and shown to be postmenopausal defined as with- 
out menstruation for >12 months, removal of both ovaries, or FSH >50 
mIU/mL. Before being admitted to the study, subjects were screened 
and found to be free of diabetes mellitus, fasting hyperlipidemia (total 
serum cholesterol ~300 mg/ dL and triglycerides ~300 mg/ dL), renal, 
or hepatic disease by medical history, physical examination, and serum 
chemistry. Seventeen out of the 38 women (10 normal weight and 7 
overweight/obese) were on estrogen or estrogen/progesterone replace- 
ment therapy. These women were all either on a stable continuous 
dosage schedule or patch. All subjects gave informed consent and the 
experimental protocols were approved by the institutional Human Sub- 
jects Review Committee of University of California, Davis. Character- 
istics of the participants are shown in Table 1. 
Weight-maintaining diets with variable fat content 
To determine the effects of dietary fat content independent of changes 
of body mass on plasma leptin concentrations, allsubjects were fed 
weight-maintaining diets at the Universitv of California, Davis Medical 
Center during the grst 4 months of the study. Menus were prepared by 
calculating the nutrient compositions of the diets with a food database 
system (Nutrition Data System, NDS93, University of Minnesota). 
The diets consisted of whole foods weighed to ? 1 g. For the first 4 
weeks, the diets consisted of 31% of energy from fat, 17% from protein, 
and 52% from carbohydrate. The following 6 weeks, the diets consisted 
TABLE 1. Characteristics of normal weight, overweight to obese, 
and all study subjects before dietary intervention 
Normal weight 
(n = 19) 
Overweight/obese 
(n = 19) 
All 
(n = 38) 
Age 60 2 2” 58 2 2 59 2 1 
Range 43-81 47-74 43-83 
Height (m) 1.63 2 0.02 1.63 2 0.02 1.63 -+ 0.01 
Ranne 1.57-1.77 1.52-1.79 1.52-1.79 
Weiiht (kg) 65.0 + 1.46 93.3 2 4.1 79.2 2 3.2 
Range 53.4-75.2 72.8-145.5 53.4-145.5 
BMI (kg/m2) 24.5 2 0.6 35.1 t 1.2 29.8 k 1.1 
Range 18.8-27.2 28.3-45.4 18.8-45.4 
of 23% of energy from fat, 17% from protein, and 60% from carbohydrate. 
During the last 6 weeks, the experimental diets consisted of 14% of 
energy from fat, 19% from protein, and 67% from carbohydrate. To 
ensure accuracy of the diets, the energy, fat, protein, and carbohydrate 
contents of the diets was verified by Hazelton Laboratories (Madison, 
WI). 
All subjects ate their weekday evening meals at the facility. Breakfast, 
lunch, and weekend meals were prepared and taken home by the par- 
ticipants Participants were given detailed instructions on the impor- 
tance of consuming all the food provided and kept daily records of any 
discrepancies. Compliance was closely monitored and noncompliant 
subjects (>l% of calories altered from the experimental diet on more 
than one occasion) were excluded from the study. Subjects were in- 
structed not to change their activity level during the experimental diet 
portion of the study. 
Initial energy intake was individualized and based on the subjects 
resting energy expenditure (REE) measured by indirect calorimetry (27, 
28) with a factor included for activity level (estimated by an activity 
questionnaire), and in accord with each subject’s BMI and body com- 
position. Subjects were weighed five times each week, and the energy 
content of the diets was adjusted by increasing or decreasing daily 
caloric intake by 150 kcal when body weight varied by >l kg to maintain 
bodv weight. The average daily caloric intake on the 31% fat diet was 
2056 2 6fkcal/day and-was increased by approximately 6% to 2170 + 
70 kcal/day by the end of the 14% fat diet (A = +120 ? 30 kcal/day, 
P < 0.0005 us. 31% fat diet). 
Self-regulated low fat diet 
To examine the effects of sustained weight loss on plasma leptin 
concentrations, after 4 months on the weight-maintaining experimental 
diets, the participants switched to a self-selected (ad libitum) very low fat 
diet for the remaining 8 months of the study. Subjects were given 
detailed instructions and support to adhere to a diet with <15% of 
energy as fat through a series of group classes and individual counseling 
sessions with a registered dietitian. Of the initial 38 women, 33 com- 
pleted the entire study (16 normal weight and 17 overweight/obese). 
The mean dietary fat content on the low fat diet (assessed by 7-day food 
records analyzed by NDS93) after 6 and 8 months on the ad libitm low 
fat diet was 12 5 1% and 11 2 l%, respectively. The average weight loss 
after 8 months was 6.9 ? 1.0%. For analysis, subjects were divided into 
two groups; 18 women who lost less than 7% ofbody mass on the low 
fat diet, and 15 women who lost more than 7% of bodv mass. Dietarv 
fat content was not significantly different between those who lost ~7% 
(10 + 1%) and those who lost >7% (12 + 1%). 
Data collection 
Body weights were measured, and fasting blood samples for analysis 
of plasma leptin, insulin, and glucose concentrations were obtained 2 
weeks after the start of the 31% fat diet, at 4 weeks after the start of the 
23% fat and 14% fat diets, and after 6 and 8 months on the self-selected 
low fat diets (10 and 12 months after the start of the study). Percent body 
fat was measured by bioelectrical impedance (Bio-Analogies, Beaverton, 
OR) during the 31%, 23%, and 14% fat experimental diets, and again at 
12 months. Measurements of percent body fat made with this instrument 
were very consistent within subjects (r = 0.9662, P < 0.0001). The co- 
efficient of variation of the percent body fat measurements within sub- 
jects averaged 4.1 + 0.5%. REE was measured at stable body weight and 
again at 12 months (27, 28). 
Assays and data analysis 
Plasma glucose concentration was measured by the glucose oxidase 
technique with a kit (Glucose Trinder, Sigma, St. Louis, MO). Immu- 
noreactive plasma human leptin concentrations were determined by 
RIA (29) with reagents supplied by Linco Research, St. Charles, MO. The 
range of the standard curve in this assay is 0.5-100 ng/mL. The intra- 
and interassay coefficients of variation are ~8%. The antibody used in 
the assay does not cross-react with human insulin, proinsulin, glucagon, 
pancreatic polypeptide, or somatostatin. Plasma insulin concentration 
was measured with a specific RIA for human insulin in plasma using an 
antibody that does not cross-react with proinsulin (Linco Research). a Mean t SEM. 
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Data are expressed as means 5 SEM. Statistical comparison of means 
within a group were made with a paired t test. Comparison of means 
of two different groups were made with a two-sample f test. Correlation 
coefficients and significance values between absolute values or changes 
of BMI, percent body fat, plasma leptin, insulin, and glucose were 
calculated by linear regression analysis. Partial regression analysis was 
performed with PC SAS (SAS Institute, Inc., Cary, NC) to examine the 
relationship between absolute or changes of plasma insulin or REE and 
leptin concentrations, independent of BMI or percent body fat. 
Results 
BMI, percent body fat, plasma leptin, insulin, and glucose 
concentrations in normal weight and overweight I obese 
women on weight-maintaining diets 
BMI was slightly (-1%) but significantly decreased on the 
14% fat diet, despite the caloric adjustments. Percent body fat 
was not different across the three weight-maintaining diets. 
Plasma insulin concentrations were doubled in obese (108 + 
12 pmol /L) US. lean (48 2 6 mmol/L) and were unaffected 
by dietary fat content. Plasma glucose was not significantly 
different between overweight/obese and normal weight 
women and decreased slightly during the 14% fat diet overall 
(from 5.6 + 0.1 to 5.5 + 0.1 mmol/L) and in the overweight/ 
obese group (from 5.7 2 0.2 to 5.5 5 0.1 mmol/L). Plasma 
leptin concentrations were more than two times higher in 
overweight/obese than in normal weight subjects and were 
not affected by varying the dietary fat content (Fig. 3). Plasma 
leptin concentrations within subjects were remarkably stable 
across the three diets (r = 0.9079-0.9587, all P < 0.0001). 
Correlations between BMI, percent body fat, plasma leptin, 
insulin and glucose concentrations at stable body weight 
As expected, BMI was highly correlated with percent body 
fat overall (r = 0.85, P < 0.0001, Fig. lA), and within both the 
normal weight (r = 0.88, P < 0.0001) and the overweight/ 
obese groups (r = 0.65, P < 0.005). Plasma leptin was highly 
correlated with BMI overall (r = 0.81, P < 0.0001, Fig. 1B) and 
within both the normal weight (r = 0.58, P < 0.001) and 
overweight/obese groups (r = 0.59, P < 0.001). Percent body 
fat was similarly well correlated with plasma leptin overall 
(r = 0.80, P < 0.0001, Fig. 1C) in normal weight (r = 0.64, P < 
0.005) and in overweight/obese subjects (r = 0.69, P < 0.002). 
Fasting plasma insulin concentrations were well corre- 
lated with BMI (r = 0.70, P < 0.0001, Fig. 2A) and with 
percent body fat (r = 0.58, P < 0.0002, Fig. 2B). Plasma leptin 
concentrations were significantly correlated with fasting 
plasma insulin (r = 0.61, P < 0.0001, Fig. 2C). However, by 
partial regression analysis, plasma insulin was not signifi- 
cantly correlated with plasma leptin independently of BMI 
or percent body fat. BMI, percent body fat, plasma leptin, and 
plasma insulin were not correlated with fasting plasma glu- 
cose levels (data not shown). 
Effects of sustained weight loss on body fat, plasma leptin, 
and plasma insulin concentrations in normal weight and 
overweight lobese women 
Thirty-three of the original 38 subjects completed the en- 
tire study. After 6 months on the self-selected low fat diet 
(month 10 of the study), the participants lost an average 4.0 ? 
0.5 kg (ABM1 = -1.6 + 0.2 kg/m2, P < 0.0001, Table 3). After 
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FIG. 1. Correlation of BMI with percent body fat (A), BMI with 
plasma leptin (B), and percent body fat with plasma leptin (C) at 
stable body weight in 19 normal weight and 19 overweight/obese 
women. 
8 months on the self-selected low fat diet (month 12 of the 
study), the average weight loss was sustained (A = -5.0 + 
0.7 kg, %ABMI = -6.9 t 1.0, P < 0.0001). Subjects were 
divided into two groups for analysis; 18 women (8 normal 
weight and 10 overweight /obese) who lost less than 7% of 
body mass (-2.3 +- 0.6 kg; % weight loss = -2.7 ? 0.6%, 
range = +3.0 to -6.3%) on the low fat diet, and 15 women 
(8 normal weight and 7 overweight /obese) who lost more 
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at stable body weight in 19 normal weight and 19 overweight/obese 
women. 
than 7% of body mass (-8.4 t 0.5 kg, % weight loss = 
-12.3 ? l.O%, range = -8.2 to -23.0%). The women with 
less than 7% weight loss had modest, but significant reduc- 
tions of percent body fat (-0.9 2 0.4%, P < 0.02), but both 
plasma leptin (Fig. 4A) and plasma insulin concentrations 
were unchanged (Table 2). Women with greater than 7% 
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FIG. 3. Plasma leptin concentrations in 19 normal weight, 19 over- 
weight/obese women, and in all 38 women on weight-maintaining 
diets containing 31%, 23%, and 14% of energy as fat. 
weight loss had predictably larger reductions of percent 
body fat (-5.6 rt 0.6%, P < O.OOOS), and in these subjects both 
plasma leptin and plasma insulin concentrations both fell by 
approximately 35% (Table 2). 
Weight loss in women losing >7% body mass was not 
different between normal weight women (A = -3.7 ? 0.4 
kg/m*) and in overweight/ obese women (A = -3.7 2 0.4 
kg/m’). Plasma leptin concentrations were decreased in both 
normal weight women and overweight/obese women who 
lost weight after 6 months on the ad libitum low fat diet, and 
the reductions were sustained after 8 months (Fig. 4B). The 
decrement of plasma leptin after weight loss was greater in 
overweight/obese women (A = -13.9 t- 2.2 ng/mL, P < 
0.0005) than in normal weight women (A = -5.7 t 2.4 ng/ 
mL, P < 0.02 VS. normal weight), however plasma leptin 
levels remained significantly higher in the overweight / obese 
women than in normal weight women (P < 0.01, Fig. 4B). 
Baseline characteristics of the subjects (age, BMI, percent 
body fat, total body fat, hormone replacement therapy, and 
family history of diabetes) and hormone/ substrate measure- 
ments (plasma leptin, insulin, and glucose concentrations) 
were evaluated to determine whether any of these param- 
eters was predictive of weight loss on the ad libitum low fat 
diet. Of these, only family history of diabetes was predictive 
of weight loss, with subjects with first degree diabetic rela- 
tives having significantly greater decreases of BMI (-2.9 2 
0.6 VS. 1.6 ? 0.3 kg/m’, P = 0.033) and percent body fat 
(-4.9 2 1.0 VS. -2.1 + 0.5%, P = 0.012) than in women 
without family history of diabetes. 
Correlation of changes of BMI, percent body fat, plasma 
leptin, insulin, and REE on a long-term low fat diet in 
normal weight and ouerweightlobese women 
As expected, the changes of BMI were highly correlated 
with the change of percent body fat after 8 months on the 
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TABLE 2. BMI, body fat, plasma leptin, and insulin in women who lost more than or less than 7% of body mass at stable body weight 
(BW) and after 6 and 8 months on an ad lib&urn low fat diet 
~7% wt loss (n = 18) 
Stable BW 
10 months 
A10 months 
12 months 
Al2 months 
BMI (kg/n?) Body fat (?‘~z) Leptin (rig/ml) Insulin (pmoi:+U/mL) 
30.1 + 1.7 33.1 5 1.4 27.8 + 4.0 84 2 12 (14 + 2) 
29.4 + 1.6 N.D. 25.7 + 3.2 102 f 18 (17 + 3) 
-0.7 + 0.2’ N.D. -2.2 + 1.4 +18 + 12 (+3 + 2) 
29.2 2 1.6 
-0.9 k 0.2d 
28.3 2 1.2 
26.1 t- 1.2 
-2.7 2 0.3d 
25.2 -+ 1.2 
-3.4 k 0.2d 
32.2 2 1.6 
-0.9 2 0.46 
29.2 -t 4.3 
+1.4 + 1.4 
26.8 2 4.0 
17.1 2 2.7 
-9.7 -t 1.8” 
17.2 2 2.6 
-9.6 k 1.9” 
27.6 t 2.6 
23.1 + 2.5 
-4.6 rt 1.4” 
25.0 + 3.0 
-2.6 k 1.6’ 
90 -c 12 (15 2 2) 
+6”6(+1?1) 
>7% wt loss (n = 15) 
Stable BW 
6 months 
A6 months 
8 months 
A8 months 
All (n = 33) 
Stable BW 
6 months 
A6 months 
8 months 
A8 months 
29.4 ? 1.1 32.9 5 1.0 
27.8 2 1.1 N.D. 
-1.6 ? 0.2d N.D. 
27.4 2 1. 29.9 ? 1.2. 
-2.0 -c 0.3d -2.9 2 0.5d 
32.5 + 1.1 
N.D. 
N.D. 
27.0 t 1.5 
-5.6 + 0.6d 
84 t- 18(14 5 3) 
60 2 12 (10 2 2) 
-24 2 12 (-4 2 2)” 
54 2 12 (9 k 2) 
-30 2 12 (-5 2 2)h 
84 rt 12 (14 2 2) 
84 + 12(14 + 2) 
0 + 12 (0 2 2) 
78 + 12 (13 + 2) 
-6?6(-121) 
Data are mean * SEM; a P < 0.05; b P < 0.025; ‘, P < 0.0025; d P < 0.0005 us. stable body weight. 
self-selected low fat diet (r = 0.78, P < 0.0001, Fig. 4A). The 
change of plasma leptin on the low fat diet across all 
subjects was significantly correlated with both the change 
of BMI (r = 0.42, P < 0.02, Fig. 4B) and with the change 
of percent body fat (r = 0.49, P < 0.005, Fig. 4C). In contrast 
to leptin, the changes of plasma insulin were not signifi- 
cantly correlated with the change of BMI (r = 0.26, P = 
0.15, data not shown) or percent body fat (r = 0.26, P = 
0.14, data not shown). However, the change of plasma 
leptin on the self-selected low fat diet correlated well with 
the change of fasting plasma insulin (r = 0.52, P < 0.002, 
Fig. 4D). In addition, by partial regression analysis, the 
change of plasma leptin was significantly correlated with 
the change of plasma insulin independent of changes of 
BMI (r = 0.45, P < 0.01) or percent body fat (r = 0.44, P < 
0.02). REE decreased by 7.7 2 2.3% (P < 0.0025) in women 
losing more than 7% body weight, but did not change in 
women who lost less than 7% body weight (data not 
shown). The change of REE was significantly correlated 
with the change of BMI (r = 0.40, P < 0.02), percent body 
fat (r = 0.45, P < O.Ol), and plasma leptin (r = 0.40, P < 
0.02), however partial correlation analysis did not reveal 
an independent relationship of any one of these variables 
with the change of REE. 
Leptin /adiposity relationships before and after weight loss 
in normal weight and overweightlobese women 
Plasma leptin/ adiposity ratios were examined in normal 
weight and overweight/obese women who lost more than or 
less than 7% of body weight before and after the long-term 
ad libitum low fat diet. Plasma leptin and adiposity (percent 
body fat) were higher in overweight/obese women than in 
normal weight women whether or not they lost more than 7% 
body weight. The plasma leptin / adiposity ratio was higher 
in overweight/obese women than in normal weight women 
(Table 3). Both normal weight and overweight/ obese women 
had significant decreases of percent body fat whether or not 
they lost more than 7% body weight, but normal weight 
women had larger absolute and proportional decreases of 
adiposity (Table 3). After 8 months on the low fat ad libitum 
diet, only overweight / obese women had a significant change 
in their leptin/adiposity ratio, which decreased by approx- 
imately 30% (Table 3). There were no significant alterations 
of the absolute change of leptin per unit adiposity (Alep- 
tin) / A% body fat) or the proportional changes of leptin per 
proportional change in adiposity (%Aleptin/ %A% body fat) 
in normal weight or overweight / obese women, overall, or in 
the women who lost less than 7% of body weight (data not 
shown). However, plasma leptin decreased with adiposity in 
normal weight and overweight/obese women who lost more 
than 7% body weight, and both the absolute changes of leptin 
per unit adiposity and the proportional changes of leptin per 
proportional change of adiposity were 2.5-3.5 times greater 
in overweight/obese women than in normal weight women 
(Table 3). 
Discussion 
The aim of this study was to determine the effects of 
dietary fat content, in the absence of weight loss, on 
plasma leptin levels in women with a wide range of ad- 
ipose tissue mass and within normal weight and over- 
weight/obese subjects. In addition, the relationship be- 
tween plasma leptin and plasma insulin levels after 
sustained weight loss on a very low fat diet was examined 
in both normal weight and overweight/ obese women. 
Plasma leptin levels were higher in overweight to obese 
women than in lean to normal weight women and were 
highly correlated with both BMI and adiposity as assessed 
by percent body fat measurements overall and within both 
the normal weight and the overweight/obese groups. El- 
evations of plasma leptin levels in obesity and correlation 
with adiposity across human subjects with a wide range 
of adiposity have been reported in two recent studies (22, 
23) but not within groups of lean or obese subjects. When 
the relationship of plasma leptin to adiposity was exam- 
ined by calculating the leptin/percent body fat ratio, we 
found that after correcting for adiposity, overweight/ 
obese women have higher plasma leptin levels per unit of 
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FIG. 4. Plasma leptin concentrations in normal weight and obese/ 
overweight women at stable body weight and after 6 and 8 months on 
a very low fat (~15%) diet. A, Eighteen women who lost less than 7% 
body weight; B, 15 women who lost more than 7% body weight. 
adiposity than normal weight women. These data are sup- 
ported by a recent study showing increased leptin pro- 
duction per unit body fat in obese humans (30). 
At stable body weight, plasma leptin levels were corre- 
lated with fasting plasma insulin. However, it is unclear 
whether this relationship between plasma insulin and leptin 
is caused by the coexisting adiposity or reflects regulation of 
plasma leptin by insulin, particularly because fasting insulin 
did not correlate with plasma leptin independently of 
adiposity. 
We found no effect of reducing the fat content of the diet 
on plasma leptin or insulin concentrations when body weight 
was maintained, even after several weeks on very low fat 
diets. Thus, plasma leptin concentrations are not altered by 
dietary fat content in the absence of weight loss or changes 
of plasma insulin levels. Furthermore, because subjects 
were fed more than they would consume nd libitutn during 
low fat intake, changing the fat content of the diet appears 
to alter the regulated level of adiposity via a mechanism 
unrelated to changes of plasma leptin or plasma insulin 
levels. In fact, the amount of body weight and fat loss on 
the nd libitum low fat diet was best related to having a first 
degree relative with diabetes, whereas other parameters 
measured in the study (adiposity, plasma leptin, plasma 
insulin, or REE) were not predictive of weight loss. This 
suggests that very low fat diets may be an effective method 
for inducing and maintaining weight loss in subjects with 
a family history of diabetes. 
After sustained weight loss of greater than 7% of body 
mass, there was a clear reduction of both plasma leptin and 
plasma insulin concentrations in normal weight and over- 
weight/obese women. However, the plasma leptin / percent 
body fat ratio, which is elevated in overweight/obese 
women, decreased after weight loss in overweight/obese but 
not in normal weight women. In addition, the absolute and 
proportional decreases of plasma leptin per unit adiposity 
after weight loss was greater in overweight/obese women 
than in normal weight women. For example, a 10% decrease 
of adiposity in obese women leads to an average 34% de- 
crease of plasma leptin, whereas the same proportional 
change of adiposity only decreases plasma leptin by an av- 
erage of 13% in normal weight women. Plasma leptin and 
insulin levels were unchanged in women who lost less than 
7% of body mass, despite a modest, but significant, average 
weight loss (-3% of body mass) and more than 10 months 
on a very low fat diet. 
The overall change of plasma leptin at the completion of 
the study was well correlated with changes of BMI on 
percent body fat. In addition, the change of plasma leptin 
was correlated with the change of fasting plasma insulin 
independently of changes of BMI or percent body fat. 
Insulin administration increases (16, 17) and insulin de- 
ficiency decreases (18, 19) leptin gene expression in ani- 
mals. However, because absolute plasma leptin and insu- 
lin levels were not independently correlated, it would 
appear to be the dynamics of insulinemia during weight 
loss that is associated with changes of plasma leptin, rather 
than the absolute plasma insulin level at stable body 
weight. Furthermore, if insulin is involved in the regula- 
tion of plasma leptin, it is unlikely to be an acute effect 
because short-term infusions of insulin did not alter 
plasma leptin in two studies in humans (31, 32). Lastly, it 
should also be noted that the findings of this study con- 
ducted in women should not be extrapolated to men, be- 
cause men have lower levels of adiposity, ob gene expres- 
sion (21), and plasma and cerebrospinal fluid leptin 
concentrations (33). 
In summary, we have found that plasma leptin is not 
altered by dietary fat content per se and is highly correlated 
with BMI, percent body fat, and plasma insulin when body 
weight is stable. Plasma leptin per unit of adiposity is nearly 
doubled in overweight/obese women compared with nor- 
mal weight women. Furthermore, there are sustained dec- 
rements of plasma leptin in both normal weight and over- 
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TABLE 3. Leptin/adiposity relationships in normal weight and overweight/obese women at stable body weight and after 8 months on an 
ad libitum low fat diet 
(n “=‘:,, 
Normal weight 
>77c wt loss 
(n = 8) 
<77c wt loss 
(n = 8) 
All 
(n = 17) 
Overweight/obese 
>77c wt loss 
(n = 7) 
<7% wt loss 
(n = 10) 
Leptin 16.7 2 1.9 17.2 2 3.8 
ALeptin -2.0 k 1.8 -5.7 2 2.4" 
%ALeptin -12.5 2 9.1 -29.4 2 11.1” 
%Body fat 28.3 2 1.0 29.8 -t 1.3 
A%Body fat -3.0 k 1.0” -6.9 + 0.8" 
%A%Body fat -13.4 2 1.8” -23.5 2 2.7" 
(Leptin/%body fat) 0.57 2 0.06 0.56 + 0.12 
A(Leptin/%body fat) -0.01 2 0.05 -0.09 -+ 0.07 
%A(Leptin/%body fat) 2.1 2 9.4 -8.4 + 13.5 
(ALeptin)l(A%body fat) 0.9 + 0.4 
(%ALeptin)/(%A%body fat) 1.3 + 0.5 
15.5 -+ 0.9 38.2 2 3.2" 
1.3 2 1.2 -3.1 2 2.6 
7.6 +- 8.5 -6.0 2 7.7 
27.6 2 1.4 37.2 t 0.7' 
-1.3 2 0.3" -2.2 -t 0.6" 
-5.0 2 0.3" -7.3 + 2.5" 
0.56 2 0.03 1.01 + 0.07b 
0.07 2 0.04 -0.07 + 0.07 
12.6 2 8.4 -3.2 + 7.7 
37.7 2 3.1b 
-13.9 2 2.1” 
-37.7 t 6.0" 
35.7 ? 0.7h 
-4.0 2 0.3",& 
-11.3 2 l.l”,b 
1.05 2 0.08’ 
-0.31 2 0.07"*b 
-29.9 2 6.0",b 
3.6 + 0.5' 
3.4 + 0.46 
37.6 + 5.8' 
1.5 + 2.3 
9.6 2 8.4' 
37.4 t l.lb 
-1.1 * 0.4” 
-3.0 5 1.1” 
0.98 2 0.13h 
0.07 2 0.06 
12.9 t 8.3 
Values are mean t SE; a P < 0.01 US. baseline; ‘P < 0.01 VS. normal weight women. 
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FIG. 5. Correlation of change of BMI (ABMI) with change of percent body fat (A), change of BMI with change of plasma leptin (B), change of 
percent body fat with change of plasma leptin (C), and change of plasma insulin with change of plasma leptin (D) in 33 normal weight and 
overweight/obese women after 12 months on study in which 15 subjects lost >7% and 18 subjects lost <7% body mass on a very low fat diet. 
weight/obese women after substantial reductions of body 
weight, but the reductions of plasma leptin are greater in 
obese than in normal weight women. The changes of plasma 
leptin concentration after weight loss are correlated with 
changes of BMI, percent body fat, and REE, and parallel the 
changes of plasma insulin independently of the change of 
adiposity. Thus, if leptin is in fact a hormonal regulator of 
feeding behavior and adiposity in humans, decreases of 
plasma leptin after weight loss could contribute to the strong 
tendency for weight regain after successful dieting. 
Acknowledgments 
We would like to acknowledge the expert technical assistance of 
Liz Rinehart and Rogelio Almario. 
PLASMA LEPTIN, INSULIN, AND ADIPOSITY 4413 
References 
1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold -L, Friedman JM. 1994 
Positional cloning of the mouse obese gene and its human homologue. Nature. 
372~425-432. 
2. Masuzaki H, Ogawa Y, Isse N, et al. 1995 Human obese gene expression. 
Adipocyte-specific expression and regional differences in the adipose tissue. 
Diabetes. 44:855-858. 
3. Rohner-Jeanrenaud F, Jeanrenaud B. 1996 Obesity, leptin, and the brain. 
N Engl J Med. 334:324-325. 
4. Pelleymounter MA, Cullen MJ, Baker MB, et al. 1995 Effects of the obese gene 
product on body weight regulation in ob/ob mice. Science. 269:540-543. 
5. H&as JL, Gajiwala KS, Maffei M, et al. 1995 Weight-reducing effects of the 
plasma protein encoded by the obese gene. Science. 269:543-546. 
6. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. 1995 Recombinant 
mouse OB protein: evidence for a peripheral signal linking adiposity and 
central neural networks. Science. 269:546-549. 
7. Weigle DS, Bukowski TR, Foster DC, et al. 1995 Recombinant ob protein 
reduces feeding and body weight in the ob/ob mouse. J Clin Invest. 
96:2065-2070. 
8. Levin N, Nelson C, Gurney A, Vandlen R, De Sauvage F. 1996 Decreased food 
intake does not completely account for adiposity reduction after ob protein 
infusion. Proc Nat1 Acad Sci USA. 93:1726-1730. 
9. Schwartz MW, Baskin DG, Bukowski TR, et al. 1996 Specificity of leptin 
action on elevated blood glucose levels and neuropeptide-Y gene expression 
in o&lob mice. Diabetes. 45:531-535. 
10. Rentsch J, Levens N, Chiesi M. 1995 Recombinant ob-gene product reduces 
food intake in fasted mice. Biochem Biophys Res Commun. 214:131-136. 
11. Stephens TW, Basinski M, Bristow PK, et al. 1995 The role of neuropeptide 
Y in the antiobesity action of the obese gene product. Nature. 377:530-532. 
12. Turton MD, O’Shea D, Gunn I, et al. 1996 A role for glucagon-like-peptide 
in the central regulation of feeding. Nature. 379:69-72. 
13. Schwartz MW, Figlewicz DP, Baskin, DG, Woods SC, Porte D. 1994 Insulin 
and the central regulation of energy balance: update 1994. In: Negro Vilar A, 
Underwood LE (eds) Endocrine Reviews Monographs 2. The Endocrine Pan- 
creas, Insulin Action, and Diabetes. Bethesda, MD: The Endocrine Society; 
81-113. 
14. De Vos P, Saladin R, Auwerx J, Staels B. 1995 Induction of ob gene expression 
by corticosteroids is accompanied by body weight loss and reduced food 
intake. J Biol Chem. 270:15958-15961. 
15. Murakami T, Iida M, Shima K. 1995 Dexamethasone regulates obese expres- 
sion in isolated rat adipocytes. Biochem Biophys Res Commun. 214~1260-1267. 
16. Saladin R, De Vos P, Guerre-Millo M, et al. 1995 Transient increase in obese 
gene expression after food intake or insulin administration. Nature. 
377527-529. 
17. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. 1995 The 
ob gene and insulin: a relationship leading to clues to the understanding of 
obesity. Diabetes. 441467-1470. 
18. MacDougald OA, Hwang CS, Fan H, Lane MD. 1995 Regulated expression 
of the obese gene product (leptin) in white adipose tissue and 3T3-Ll adipo- 
cytes. Proc Nat1 Acad Sci USA. 92:9034-9037. 
19. Becker DJ, Ongemba LN, Brichard V, Henquin JC, Brichard SM. 1995 Diet- 
and diabetes-induced changes of ob gene expression in rat adipose tissue. Febs 
Lett. 371:324-328. 
20. Shafrir E. 1990 Diabetes in animals In: Rifkin H, Porte D (eds) Ellenberg and 
Rifkin’s Diabetes Mellitos: Theory and Practice. New York: Elsevier Press; 
299-340. 
21. Lonnqvist F, Amer P, Nordfors L, Schalling M. 1995 Overexpression of the 
obese (ob) gene in adipose tissue of human obese subjects. Nature Med. 
1:950-953. 
22. Maffei M, Halaas J, Ravussin E, et al. 1995 Leptin levels in human and rodents 
measurement of plasma leptin and ob RNA in obese and weight-reduced 
subjects. Nature Med. 1:1155-1161. 
23. Considine RV, Sinha MK, Heiman ML, et al. 1996 Serum immunoreactive- 
leptin concentrations in normal-weight and obese humans. New Engl J Med. 
334:292-295. 
24. Mizuno TM, Bergen H, Funabashi T, et al. 1996 Obese gene expression: 
reduction by fasting and stimulation by insulin and glucose in lean mice and 
persistent elevation in acquired (diet-induced) and genetic (yellow agouti) 
obesity. Proc Nat1 Acad Med USA. 93:34343438. 
25. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. 1995 
Leptin levels reflect body lipid content in mice: evidence for diet-induced 
resistance to leptin action. Nature Med. 1:1311-1314. 
26. Have1 PJ, Ahren B. 1996 Plasma leptin and insulin: effects of a high fat diet 
and fasting in two mouse strains. Diabetologia. 39(Suppl. l):A146. 
27. Phinney SD, Davis PG. 1990 Differential effects of two very low-fat diets on 
aerobic and anaerobic exercise performance. Int J Obesity. 14779-787. 
28. Taffe DR, Thompson J, Butterfield G, Marcus R. 1995 Accuracy of equa- 
tions to predict basal metabolic rate in older women. J Am Diet Ass. 
5:1387-1392. 
29. Ma ZA, Gingerich RL., Santiago JV, Klein S, Smith HC, Landt M. 1996 
Radioimmunoassay of leptin in human plasma. Clin Chem. 42942-946. 
30. Klein S, Coppack SW, Mohamed-Ali V, Landt M. 1996 Adipose tissue leptin 
production and plasma leptin kinetics in humans. Diabetes. 45:984-987. 
31. Dagogo-Jack S, Fanelli C, Paramore D., Brothers J., Landt M. 1996 Plasma 
leptin and insulin relationships in obese and nonobese humans. Diabetes. 
45:695-698. 
32. Kolaczynski JW, Nyce MR, Considine RV, et al. 1996 Acute and chronic 
effects of insulin on leptin production in humans: studies !t? z~ioo and in z~itro. 
Diabetes. 45:699-701. 
33. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D. 1996 Cerebrospinal 
fluid leptin levels: relationship to plasma levels and to adiposity in humans. 
Nature Med. 2:589-593. 
